Global Infectious Disease Diagnostics Market (2020 to 2025) – Featuring Biomrieux, Abbott Laboratories & Becton, Dickinson and Company Among Others –

DUBLIN–(BUSINESS WIRE)–The “Infectious Disease Diagnostics Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to’s offering.

Infectious diseases are one of the leading causes of morbidity and mortality across the globe. Diagnostics is the primary step for disease discovery and treatment leading to the eradication of infectious diseases. Owing to ever-evolving pathogens and emerging new diseases, there is dire need to identify suitable diagnostics technique that can help physicians to decide the appropriate treatment. This can also help to control the outbreak of the disease in the population.

Technological advancement has rapidly changed the landscape of infectious disease diagnostics. Scientific research and development activities in novel technologies and techniques such as mass spectrometry and next-generation sequencing (NGS) are changing the way how rapid diagnostics are being performed to detect diseases. In addition, the growing inclination of end-user towards point-of-care testing is also anticipated to drive industry growth.

Key Market Trends

Viral Infection diagnostics are expected to cover a large share of the market

A viral infection is one of the major public health concerns around the world. As per a report by Meryem Jefferies et al. published in the World Journal of Clinical Cases 2018, every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. Furthermore, according to the World Health Organization, 37.9 million people were living with HIV/AIDS worldwide in 2018. Moreover, an estimated 32 million people have died of HIV.

Thus, owing to the high prevalence of these dreadful illnesses, the demand for early diagnostic tests is expected to increase as early diagnosis may reduce the spread of the disease. Hence, this market is expected to increase in the future.

North America is expected to Hold Largest Market Share

According to Charbel el Bcheraoui et al. published in the Journal of the American Medical Association 2018, between 1980 and 2014, there were more than 4 million deaths due to infectious diseases recorded in the United States. In 2014, a total of more than 110,000 deaths (a rate of 34.10 deaths per 100000 persons) were due to infectious diseases in the United States compared to a total of approximately 72,000 deaths (a rate of 41.95 deaths per 100000 persons) in 1980.

As the United States is a developed economy, it has a well-structured healthcare system. This has helped the country with better access to the diagnostic tests that are available in the market. Diagnostic tests help early diagnosis of a disease that can help the spread of these infectious diseases. As a result, this can be noticed in the decreasing rate of infectious diseases over the years. However, the rate still remains high, which is expected to help the growth of this market.

Key Topics Covered:





4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Global Prevalence of Infectious Diseases

4.2.2 Shift in Focus From Centralized Laboratories to Decentralized Point-Of-Care Testing

4.2.3 Research on Infectious Disease Diagnostics

4.3 Market Restraints

4.3.1 Inadequate Reimbursements

4.3.2 Rising Healthcare Costs Limiting the Use of Novel Diagnostic Techniques

4.4 Porter’s Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 By Application

5.1.1 Hepatitis

5.1.2 Human Immunodeficiency Virus (HIV)

5.1.3 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)

5.1.4 Hospital-Acquired Infections

5.1.5 Human Papillomavirus (HPV)

5.1.6 Tuberculosis (TB)

5.1.7 Influenza

5.1.8 Other Infectious Diseases

5.2 By Product

5.2.1 Assays, Kits, & Reagents

5.2.2 Instruments

5.2.3 Services & Software

5.3 By Technology

5.3.1 Polymerase Chain Reaction (PCR)

5.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT)

5.3.3 Immunodiagnostics

5.3.4 DNA Microarray

5.3.5 Clinical Microbiology

5.3.6 DNA Sequencing & Next-Generation Sequencing (NGS)

5.3.7 Others

5.4 Geography

5.4.1 North America

5.4.2 Europe

5.4.3 Asia Pacific

5.4.4 Middle East and Africa

5.4.5 South America


6.1 Company Profiles


Companies Mentioned

  • Biomrieux SA
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Siemens AG
  • Thermo Fisher Scientific
  • Quidel Corporation
  • Luminex

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900